Neglected Potential, Institutional Dynamics and Reform Pathways in Indian Sports Governance
London Journal of Research In Science: Natural and Formal · 25.05.2026
DOI: 10.34257/ljrs228094uk ↗Kurz gefasst
Fachartikel in der Zeitschrift London Journal of Research In Science: Natural and Formal, online erschienen am 25.05.2026. Verfasst von Mr. Atul Raghav. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
India’s sports ecosystem is undergoing a meaningful transformation. Government investment in sport has reached its highest-ever level in the Union Budget 2026-27, with a total allocation of Rs. 4,479.88 crore for the Ministry of Youth Affairs and Sports, reflecting an 18% year-on-year increase. Programs such as Khelo India, the Target Olympic Podium Scheme (TOPS), and the newly launched Khelo India Mission signal a decisive shift toward structured, long-term athlete development. While structural challenges persist in areas of governance coordination, equitable state-level fund distribution, and post-retirement athlete support, the overall direction is encouraging. This paper examines India’s sports governance landscape with updated data as of 2026, highlights ongoing reform efforts, and recommends targeted measures to strengthen athlete welfare, transparency, and cross-disciplinary growth across the country.
Zitieren
APA
Raghav, M. A. (2026). Neglected Potential, Institutional Dynamics and Reform Pathways in Indian Sports Governance. London Journal of Research In Science: Natural and Formal. https://doi.org/10.34257/ljrs228094uk
Vancouver
Raghav MA. Neglected Potential, Institutional Dynamics and Reform Pathways in Indian Sports Governance. London Journal of Research In Science: Natural and Formal. 2026. doi:10.34257/ljrs228094uk
BibTeX
@article{Raghav2026,
author = {Raghav, Mr. Atul},
title = {Neglected Potential, Institutional Dynamics and Reform Pathways in Indian Sports Governance},
journal = {London Journal of Research In Science: Natural and Formal},
year = {2026},
doi = {10.34257/ljrs228094uk}
}
EUVIMED